Anti-IL-17A antibody-associated de novo vitiligo: Case report and review of literature

Overview of attention for article published in Frontiers in immunology, January 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 11 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 50,831 followers.

Anti-IL-17A antibody-associated de novo vitiligo: Case report and review of literature https://t.co/uB378jKlg3 https://t.co/13BicgRpcw

19 Jan 2023

Reply Repost Favourite

RT @FrontImmunol: New Research: Anti-IL-17A antibody-associated de novo vitiligo: Case report and review of literature: Interleukin (IL)-17…

19 Jan 2023

Reply Repost Favourite

New Research: Anti-IL-17A antibody-associated de novo vitiligo: Case report and review of literature: Interleukin (IL)-17 inhibitor is a biological therapy approved for moderate to severe psoriasis and psoriatic arthritis. The common adverse… https://t.co/

19 Jan 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.